13F HOLDINGS REPORT
Madison Avenue Partners, LP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001801265-25-000004
Total Value
$1.18B
Positions
22
Other Managers
0
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GRAHAM HLDGS CO | GHM | 245,271 | $235.7M | 20.01% |
| 2 | SOLVENTUM CORP | SOLV | 2,813,017 | $213.9M | 18.16% |
| 3 | MARKEL GROUP INC | MKL | 91,357 | $170.8M | 14.50% |
| 4 | WILEY JOHN & SONS INC | 968223206 | 2,208,066 | $98.4M | 8.35% |
| 5 | THERAVANCE BIOPHARMA INC | TBPH | 9,511,150 | $84.9M | 7.21% |
| 6 | INDIVIOR PLC | INDV | 7,792,089 | $74.3M | 6.30% |
| 7 | MAGNERA CORP | MAGN | 3,344,005 | $60.7M | 5.16% |
| 8 | PG&E CORP | PCG-PX | 2,950,000 | $50.7M | 4.30% |
| 9 | INNOVEX INTERNATIONAL INC | INVX | 2,413,608 | $43.3M | 3.68% |
| 10 | STAGWELL INC | STGW | 7,147,662 | $43.2M | 3.67% |
| 11 | SAGE THERAPEUTICS INC | 78667J108 | 4,477,798 | $35.6M | 3.02% |
| 12 | NELNET INC | NNI | 233,830 | $25.9M | 2.20% |
| 13 | COLUMBUS MCKINNON CORP N Y | CMCO | 619,343 | $10.5M | 0.89% |
| 14 | ACELYRIN INC | 00445A100 | 4,142,640 | $10.2M | 0.87% |
| 15 | CANNAE HLDGS INC | CNNE | 418,984 | $7.7M | 0.65% |
| 16 | FRANKLIN STR PPTYS CORP | 35471R106 | 2,733,418 | $4.9M | 0.41% |
| 17 | 2SEVENTY BIO INC | 901384107 | 579,895 | $2.9M | 0.24% |
| 18 | PLIANT THERAPEUTICS INC | PLRX | 1,675,043 | $2.3M | 0.19% |
| 19 | OVID THERAPEUTICS INC | OVID | 2,465,623 | $769,028 | 0.07% |
| 20 | SHARKNINJA INC | SN | 6,152 | $513,138 | 0.04% |
| 21 | CARGO THERAPEUTICS INC | 14179K101 | 100,952 | $410,874 | 0.03% |
| 22 | ACADIA HEALTHCARE COMPANY INC | ACHC | 9,486 | $287,616 | 0.02% |